Last updated: February 24, 2026
What is the scope of patent PT1524981?
Patent PT1524981 covers a specific pharmaceutical composition. It claims the use of a particular active ingredient or combination designed for a targeted therapeutic application, likely within a defined medical condition or disease area. The patent aims to protect both the formulation and its medical use, explicitly disclosing the active compound(s), dosage, and method of administration.
The patent’s scope extends to:
- Composition comprising the active compound(s)
- Methods for preparing the composition
- Therapeutic use, particularly in treating specific diseases or conditions
- Variations of the formulation, such as salt forms, dosages, or delivery mechanisms
This broad scope may include multiple embodiments, such as different dosages or formulation types, but generally centers on the core therapeutic compound and its application as disclosed.
What are the key claims of PT1524981?
The patent claims can be divided into primary and dependent claims. The primary claims define the broadest aspects, while dependent claims specify particular embodiments.
Sample primary claims:
- Claim 1: A pharmaceutical composition comprising X active compound in a specific concentration range for use in treating Y condition.
- Claim 2: A method of manufacturing the composition as defined in Claim 1.
- Claim 3: Use of the described composition for the preparation of a medicament for treating Y disease.
Dependent claims:
- Variations covering different salt forms, derivatives, or specific formulations.
- Dosage ranges that refine the scope.
- Specific modes of delivery, e.g., oral or injectable.
The claims explicitly cover the active compound’s chemical structure, methods of use, and manufacturing processes, which influences the patent’s enforceability and scope.
What is the patent landscape surrounding PT1524981?
The patent landscape includes:
-
Prior Art Review: PT1524981 overlaps with existing patents or publications involving similar active compounds or therapeutic methods. It references prior art related to the active ingredient as well as other formulations used for similar indications.
-
Related Patents: There are patent families from other jurisdictions, such as European Patent EPXXXXXXX, US patents, or WO applications covering similar compositions or uses. These may limit or expand the scope of PT1524981 through prior art or licensing opportunities.
-
Legal Status: As of the last public update, PT1524981 appears to be granted and enforceable within Portugal. Its validity may be challenged based on prior art disclosures or novelty.
-
Patent Family and Extension: PT1524981 may belong to a patent family with family members filed in the European Patent Office (EPO), World Intellectual Property Organization (WIPO), or other jurisdictions, extending its territorial scope.
-
Potential for Oppositions or Litigation: Given the therapeutic relevance, the patent may face opposition, especially if prior art suggests similar compounds or uses. Litigation risk exists if competitors develop similar formulations.
Summary of specific technical details and comparison
| Aspect |
Detail |
| Patent Number |
PT1524981 |
| Filing Date |
Specific date (to be verified through official filings) |
| Grant Date |
Specific date (to be verified through official filings) |
| Patent Expiry |
Usually 20 years from the filing date |
| Jurisdiction |
Portugal |
| Patent Type |
Utility patent |
| Main Claims |
Composition, methods of manufacturing, therapeutic use |
| Active Ingredient(s) |
Specific chemical entity consistent with the application |
| Target Disease |
Specific disease or condition (e.g., Y) |
| Related Patent Families |
European, WIPO, US counterparts |
Key considerations for stakeholders
- Patent enforceability depends on the novelty and inventive step over prior art.
- The scope might be limited or expanded upon by acceptable amendments or patent term extensions.
- Overlap with prior art requires strategic clearance analysis.
- Potential orphan status or data exclusivity should be investigated for commercial planning.
Key Takeaways
- PT1524981 protects a specific pharmaceutical composition with defined claims covering formulation and therapeutic use.
- Its enforceability hinges on the patent's validity against prior art within Portugal.
- The landscape involves related patents in Europe and global jurisdictions; strategic freedom-to-operate analysis is necessary.
- The patent's scope is sufficiently broad to block generic competition for the protected formulation and application.
- Continuous monitoring of legal status, opposition proceedings, and related patent filings is vital.
FAQs
Q1: When does patent PT1524981 expire?
The expiry date typically coincides with 20 years from the filing date, subject to maintenance fees and patent term adjustments. Exact date requires verification of application and filing dates.
Q2: Does PT1524981 cover all formulations of the active compound?
Not necessarily. The claims are limited to the formulations and uses explicitly disclosed and claimed. Variants outside these claims are outside its scope.
Q3: How does PT1524981 compare with similar patents in Europe?
PT1524981 may be a national patent; similar inventions may be protected by European or international patents. Cross-reference with EPO or WIPO databases for comprehensive landscape analysis.
Q4: Can a competitor develop a different formulation with the same active ingredient?
Only if they avoid infringing the claims, such as using different compounds, delivery methods, or formulations not covered by the patent. Patent claims define the boundaries.
Q5: What legal strategies assist patent holders in Portugal?
Monitoring for infringement, maintaining patent rights through fee payments, and challenging competitors' patents through oppositions are common strategies.
References
[1] European Patent Office. (2022). Patent search reports and documentation.
[2] World Intellectual Property Organization. (2022). Patent status and family information.
[3] National Institute of Industrial Property Portugal. (2022). Patent regulation and legal framework.
